TERT and osteosarcoma: Data from the current study provides strong evidence that constitutive TERT expression leads to not only reduced intracellular ROS levels, but also significant inhibition of the mitochondrial pathway of apoptosis induced by cisplatin, promoting resistance of osteosarcoma cells to cisplatin therapy.